Literature DB >> 6277376

Diglyceride kinase from Escherichia coli. Modulation of enzyme activity by glycosphingolipids.

E Bohnenberger, H Sandermann.   

Abstract

Diglyceride kinase was purified from membranes of Escherichia coli K-12 using organic solvents. The enzyme apoprotein depended on lipids, such as cardiolipin (diphosphatidylglycerol), phosphatidylcholine or 1-monooleoylglycerol, for activity with 1,2-dipalmitoylglycerol. Mixed brain cerebrosides and gangliosides as well as defined ganglioside fractions and synthetic lactocerebroside were devoid of lipid cofactor activity. However, all these glycosphingolipids were strong inhibitors of activation by phosphatidylcholine. When cardiolipin was used as lipid activator with the detergent, Triton X-100, as solubilizing agent, the addition of mixed or purified gangliosides first (at about 0.4 mM) resulted in additional activation, but higher ganglioside concentrations were strongly inhibitory. Both effects were absolutely dependent on the presence of lipid-bound sialic acid and were not given by cerebrosides, by free sialic acid or by sialyl-lactose. The stimulating and inhibitory effects of glycosphingolipids could also be demonstrated when 1-monooleoylglycerol was used as substrate, lipid activator and solubilizing agent at the same time. The modulation of kinase activity by glycosphingolipids is discussed at the level of lipid/protein interactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277376     DOI: 10.1016/0005-2736(82)90033-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Lipid cubic phase as a membrane mimetic for integral membrane protein enzymes.

Authors:  Dianfan Li; Martin Caffrey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 2.  Prokaryotic diacylglycerol kinase and undecaprenol kinase.

Authors:  Wade D Van Horn; Charles R Sanders
Journal:  Annu Rev Biophys       Date:  2011-12-20       Impact factor: 12.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.